Dementia News and Research

Latest Dementia News and Research

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

With many hundreds of thousands of deaths due to the current COVID-19 pandemic, there is a rush to find an effective vaccine or drug against the virus. A new study on the preprint server medRxiv* in May 2020 shows that the use of some biologically plausible drugs may be counterproductive, and care should be taken when trying out unproven therapies.

22 May 2020

Lowering blood pressure reduces risk of developing dementia, research shows

Research completed in NUI Galway has shown that lowering blood pressure by taking blood pressure medications reduces the risk of developing dementia and cognitive impairment by 7%.

21 May 2020

Exercise boosts blood flow into brain regions associated with memory

Scientists have collected plenty of evidence linking exercise to brain health, with some research suggesting fitness may even improve memory. But what happens during exercise to trigger these benefits?

20 May 2020

A new treatment option for activating cellular defenses against neurodegenerative disease

Talk about motherly instincts: Biologists at the University of Iowa have learned that female roundworms can alert their future offspring of dangers they will encounter when born, and the mothers pass on these warnings even before the offspring have been conceived.

19 May 2020

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.

18 May 2020

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

The Critical Path Institute and Provention Bio, Inc. are proud to announce their collaboration to significantly improve the scientific community's insight into type 1 diabetes through Provention's contribution of data from the Phase III Protégé study of teplizumab to the T1D Trial Outcome Measures Initiative integrated database.

13 May 2020

Simple molecular reagents to fight against neurodegenerative disorders

Sometimes the most complex problems actually have very simple solutions. A group of South Korean researchers reported an efficient and effective redox-based strategy for incorporating multiple functions into simple molecular reagents against neurodegenerative disorders.

11 May 2020

Exposure to racial residential segregation associated with worse cognitive performance in mid-life

A study at Columbia University Mailman School of Public Health found that black subjects who were exposed to highly segregated neighborhoods in young adulthood exhibited worse performance in cognitive skills in mid-life.

9 May 2020

Study shows how long-term use of acid suppressants could increase risk of dementia

Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.

8 May 2020

Vitamin D could improve outcomes in COVID-19

A new study published on the preprint server medRxiv* in May 2020 shows that vitamin D could have a beneficial effect on the course of illness for COVID-19 patients.

7 May 2020

New app to be developed to protect carers, support workers during COVID-19 pandemic

Three University of Stirling projects will play a key role in safeguarding carers and support workers during the COVID-19 pandemic - and assessing the impact the experience has on them.

7 May 2020

Researchers identify changes in the aging brain related to blood circulation

Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

7 May 2020

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Older adults who consumed small amounts of flavonoid-rich foods, such as berries, apples and tea, were two to four times more likely to develop Alzheimer's disease and related dementias over 20 years compared with people whose intake was higher, according to a new study led by scientists at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.

6 May 2020

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

An international team led by Emory scientists has gained insight into the pathological mechanisms behind two devastating neurodegenerative diseases.

6 May 2020

Study explores the impact of lockdown on older people with or without dementia

It has long been known that disrupted sleep can increase the risk of dementia and anecdotal evidence suggests COVID-19 anxiety is having a detrimental effect on sleep.

6 May 2020

Researchers develop AI algorithm to accurately predict risk for and diagnose Alzheimer's

Researchers have developed a computer algorithm based on Artificial Intelligence that can accurately predict the risk for and diagnose Alzheimer's disease using a combination of brain magnetic resonance imaging, testing to measure cognitive impairment, along with data on age and gender.

4 May 2020

As COVID-19 lurks, families are locked out of nursing homes. Is it safe inside?

Families are beset by fear and anxiety as COVID-19 makes inroads at nursing homes across the country, threatening the lives of vulnerable older adults.

4 May 2020

AI-based technology could help accelerate clinical trials for glaucoma

The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.

4 May 2020

Scripps professor receives Research Program Award for advancing RNA-targeting medicines

In recognition of his high-impact work advancing the field of RNA-targeting medicines, the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, has awarded Scripps Research Chemistry Professor Matthew Disney, PhD, a prestigious Research Program Award, to aid Disney's development of treatments for incurable diseases such as Alzheimer's, Parkinson's, ALS and frontotemporal dementia.

4 May 2020

The medical consequences of anabolic-androgenic steroid use in men

A paper published in Psychotherapy and Psychosomatics, provides a careful analysis of the medical consequences of anabolic-androgenic steroid use in men.

30 Apr 2020

Dementia News and Research

Latest Dementia News and Research

IL-6 blocker use in severe COVID-19 increases risk of secondary infections

Lowering blood pressure reduces risk of developing dementia, research shows

Exercise boosts blood flow into brain regions associated with memory

A new treatment option for activating cellular defenses against neurodegenerative disease

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

C-Path, Provention Bio collaborate to improve scientific community's insight into type 1 diabetes

Simple molecular reagents to fight against neurodegenerative disorders

Exposure to racial residential segregation associated with worse cognitive performance in mid-life

Study shows how long-term use of acid suppressants could increase risk of dementia

Vitamin D could improve outcomes in COVID-19

New app to be developed to protect carers, support workers during COVID-19 pandemic

Researchers identify changes in the aging brain related to blood circulation

Study examines the link between flavenoid-rich foods and risk of Alzheimer’s disease

Scientists gain new insight into the pathological mechanisms behind two neurodegenerative diseases

Study explores the impact of lockdown on older people with or without dementia

Researchers develop AI algorithm to accurately predict risk for and diagnose Alzheimer's

As COVID-19 lurks, families are locked out of nursing homes. Is it safe inside?

AI-based technology could help accelerate clinical trials for glaucoma

Scripps professor receives Research Program Award for advancing RNA-targeting medicines

The medical consequences of anabolic-androgenic steroid use in men

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Dementia News and Research

Latest Dementia News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in